This multi-state settlement addresses makers of generic versions of opioids and is up to $720 million, officials said.

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

Connecticut Attorney General William Tong said Thursday that the state will receive a portion of approximately $720 million ...

India is the largest supplier of generic drugs, accounting for about 20% of the global supply. It manufactures about 60,000 ...

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

Amazon Prime Day 2025 deals on Thunderbolt docks and USB-C hubs are on now! We've rounded up all the best deals from Anker to ...

The news comes as the administration is pushing for pharmaceutical manufacturers reshore drug production in the United States.

Clinuvel also focuses on increasing coverage and reimbursement support. In the US, Scenesse is well covered by over 100 national and local private insurers, as well as Medicare and Medicaid. Billing ...